Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABUS
CBLL
Add up to 3 more stocks
ABUS
Arbutus Biopharma Corp
-3.53%
$4.50-0.17Delayed quote: Oct 6, 2026, 12:35 PM EDT
Market Cap
$889.91M
52W Range
$3.50 - $5.45
CBLL
CeriBell, Inc.
-0.82%
$24.66-0.20Delayed quote: Oct 6, 2026, 12:35 PM EDT
Market Cap
$935.48M
52W Range
$10.85 - $25.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 5.77 | N/A |
| Forward P/E | 6.09 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.44 | 7.29 |
| P/S Ratio | 4.90 | 9.17 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 5.94 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 88.9% |
| Operating Margin | -192.1% | -68.6% |
| Net Margin | 84.2% | -64.7% |
| ROE | 59.2% | -51.4% |
| ROA | 55.9% | -39.7% |
| ROIC | 54.4% | -46.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 81.42 | 9.18 |
| Quick Ratio | 81.42 | 8.79 |
| Debt/Equity | 0.01 | 0.17 |
| Interest Coverage | -278.88 | -30.90 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.